{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:25:13Z","timestamp":1792409113634,"version":"4.4.0"},"publisher-location":"Chichester, UK","reference-count":64,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001333.pub3","type":"reference-entry","created":{"date-parts":[[2011,2,4]],"date-time":"2011-02-04T13:28:18Z","timestamp":1296826098000},"source":"Crossref","is-referenced-by-count":129,"title":["Oral naltrexone maintenance treatment for opioid dependence"],"prefix":"10.1002","author":[{"given":"Silvia","family":"Minozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Vecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Davoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Kirchmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Verster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,16]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD001333.pub3-BIB1|cit1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0740-5472(97)00020-2","article-title":"Naltrexone pharmacotherapy for opioid dependent federal probationers","volume":"14","author":"Cornish","year":"1997","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1002\/14651858.CD001333.pub3-BIB2|cit2","first-page":"67","article-title":"Patients response to naltrexone: issues of acceptance, treatment effects, and frequency of administration","volume":"9","author":"Curran","year":"1976","journal-title":"NIDA Research Monograph Series"},{"issue":"4","key":"10.1002\/14651858.CD001333.pub3-BIB3|cit3","first-page":"2","article-title":"Efficacy of naltrexone Hydrochloride for preventing relapse among opiate-dependent patients after detoxification","volume":"11","author":"Guo","year":"2001","journal-title":"Hong Kong Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD001333.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/archpsyc.1978.01770270085008","article-title":"Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists","volume":"35","author":"Hollister","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD001333.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jsat.2004.02.002","article-title":"Naltrexone for heroin dependence treatment in St Petersburg, Russia","volume":"26","author":"Krupitsky","year":"2004","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1002\/14651858.CD001333.pub3-BIB6|cit6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jsat.2006.05.005","article-title":"Naltrexone with or without fluoxitine for preventing relapse to heroin addiction in St. Petersburg, Russia","volume":"31","author":"Krupitsky","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1002\/14651858.CD001333.pub3-BIB7|cit7","first-page":"247","article-title":"Naltrexone - an effective aid in the psychosocial rehabilitation process of former opiate dependent patients","volume":"47","author":"Ladewig","year":"1990","journal-title":"Therapeutische Umschau"},{"issue":"1","key":"10.1002\/14651858.CD001333.pub3-BIB8|cit8","first-page":"36","article-title":"A naltrexone double-blind placebo controlled study in Israel","volume":"29","author":"Lerner","year":"1992","journal-title":"Israel Journal of Psychiatry and Related Sciences"},{"key":"10.1002\/14651858.CD001333.pub3-BIB9|cit9","first-page":"26","article-title":"Naltrexone and behaviour therapy for heroin addiction","volume":"25","author":"Rawson","year":"1979","journal-title":"NIDA Research Monograph Series"},{"issue":"8","key":"10.1002\/14651858.CD001333.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1360-0443.1991.tb01859.x","article-title":"Follow-up after a six-month maintenance period on naltrexone versus placebo in heroin addicts","volume":"86","author":"San","year":"1991","journal-title":"British Journal of Addiction"},{"key":"10.1002\/14651858.CD001333.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1016\/S0140-6736(08)60954-X","article-title":"Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double blind , placebo controlled trial","volume":"371","author":"Schottenfield","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD001333.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0006-3223(94)91240-8","article-title":"The efficacy of naltrexone in preventing re abuse of heroin after detoxification","volume":"35","author":"Shufman","year":"1994","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD001333.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.lfs.2005.05.036","article-title":"Nalltrexone plus benzodiazepines aids abstinence in opioid-dependents patients","volume":"77","author":"Stella","year":"2005","journal-title":"Life Science"},{"issue":"3","key":"10.1002\/14651858.CD001333.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/10826087609056165","article-title":"Opiate antagonists and the modification of heroin self-administration behaviour in man: an experimental study","volume":"11","author":"Altman","year":"1976","journal-title":"The International Journal of the Addictions"},{"issue":"2","key":"10.1002\/14651858.CD001333.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0376-8716(81)90110-1","article-title":"Multiple family therapy and naltrexone in the treatment of opiate dependence","volume":"8","author":"Anton","year":"1981","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD001333.pub3-BIB16|cit16","first-page":"275","article-title":"Abstinence treatments for opiate addicts: therapeutic community or naltrexone?","volume":"49","author":"Arndt","year":"1984","journal-title":"NIDA Research Monograph Series"},{"issue":"10","key":"10.1002\/14651858.CD001333.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archpsyc.1977.01770220063007","article-title":"Naltrexone and cyclazocine. A controlled treatment study","volume":"34","author":"Brahen","year":"1977","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001333.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/00952997809028001","article-title":"Controlled clinical study of naltrexone side effects comparing first-day doses and maintenance regimens","volume":"5","author":"Brahen","year":"1978","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"6","key":"10.1002\/14651858.CD001333.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/10826088009040057","article-title":"The treatment of heroin addiction: naltrexone alone and with behaviour therapy","volume":"15","author":"Callahan","year":"1980","journal-title":"The International Journal of the Addictions"},{"issue":"9","key":"10.1002\/14651858.CD001333.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1176\/ajp.142.9.1081","article-title":"Naltrexone-induced dysphoria in former opioid addicts","volume":"142","author":"Crowley","year":"1985","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001333.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0740-5472(94)00077-8","article-title":"Clonidine and opiate receptor antagonists in the treatment of heroin addiction","volume":"12","author":"Gerra","year":"1995","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9","key":"10.1002\/14651858.CD001333.pub3-BIB22|cit22","first-page":"25","article-title":"Naltrexone: a clinical perspective","volume":"45","author":"Greenstein","year":"1984","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001333.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/1097-4679(198601)42:1<185::AID-JCLP2270420132>3.0.CO;2-W","article-title":"Psychosocial factors in outcome in two opiate addiction treatments","volume":"42","author":"Grey","year":"1986","journal-title":"Journal of Clinical Psychology"},{"issue":"3","key":"10.1002\/14651858.CD001333.pub3-BIB24|cit24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0376-8716(77)90027-8","article-title":"Naltrexone treatment of opiate-dependent persons","volume":"2","author":"Hollister","year":"1977","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1002\/14651858.CD001333.pub3-BIB25|cit25","first-page":"48","article-title":"Varying clinical contexts for administering naltrexone","volume":"9","author":"Hurzeler","year":"1976","journal-title":"NIDA Research Monograph"},{"issue":"8","key":"10.1002\/14651858.CD001333.pub3-BIB26|cit26","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/archpsyc.1983.01790070024003","article-title":"Methadyl acetate (LAAM) in the treatment of heroin addicts","volume":"40","author":"Judson","year":"1983","journal-title":"Archieves of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD001333.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0376-8716(81)90049-1","article-title":"Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison","volume":"7","author":"Judson","year":"1981","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1002\/14651858.CD001333.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0376-8716(84)90003-6","article-title":"Naltrexone treatment of heroin addiction: one-year follow-up","volume":"13","author":"Judson","year":"1984","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1002\/14651858.CD001333.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3109\/10826087809039316","article-title":"Narcotic antagonist treatment: clinical experience with naltrexone","volume":"13","author":"Lewis","year":"1978","journal-title":"The International Journal of the Addictions"},{"issue":"6","key":"10.1002\/14651858.CD001333.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/archpsyc.1973.01750360022003","article-title":"Naltrexone, an antagonist for the treatment of heroin dependence","volume":"28","author":"Martin","year":"1973","journal-title":"Archieves of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001333.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-3565(25)32374-8","article-title":"Operant analysis of human heroin self-administration and the effects of naltrexone","volume":"216","author":"Mello","year":"1981","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD001333.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0376-8716(94)90161-9","article-title":"Determination of naltrexone dosage for narcotic agonist blockade in detoxified Asian addicts","volume":"34","author":"Navaratnam","year":"1994","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1002\/14651858.CD001333.pub3-BIB33|cit33","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/00952990600918973","article-title":"Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?","volume":"32","author":"Nunes","year":"2006","journal-title":"Am J Drug Alcohol Abuse."},{"issue":"3-4","key":"10.1002\/14651858.CD001333.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/00952997509005662","article-title":"Clinical experience with naltrexone","volume":"2","author":"O\u00b4Brien","year":"1975","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"4","key":"10.1002\/14651858.CD001333.pub3-BIB35|cit35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/00952998609016877","article-title":"Psychosocial adjustment, modality choice and outcome in naltrexone versus methadone treatment","volume":"12","author":"Osborn","year":"1986","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"4","key":"10.1002\/14651858.CD001333.pub3-BIB36|cit36","first-page":"301","article-title":"Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence.","volume":"18","author":"Raby","year":"2009","journal-title":"Am J Addict. 2009 Jul-2009 Aug 31; 18(4):301-8"},{"issue":"1","key":"10.1002\/14651858.CD001333.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.drugalcdep.2004.02.003","article-title":"A randomised, controlled trial of low dose naltrexone for the treatment of opioid dependence","volume":"75","author":"Rea","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1002\/14651858.CD001333.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1176\/ajp.131.6.646","article-title":"Studies of EN-1639A (Naltrexone): a new narcotic antagonist","volume":"131","author":"Resnick","year":"1974","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD001333.pub3-BIB39|cit39","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0740-5472(02)00301-X","article-title":"Behavioral naltrexone therapy: Efficacy of a new behavioral treatment for heroin dependence and future directions","volume":"23","author":"Rothenberg","year":"2002","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1002\/14651858.CD001333.pub3-BIB40|cit40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/00952997809007017","article-title":"Craving in heroin addicts maintained on the opiate antagonist naltrexone","volume":"5","author":"Sideroff","year":"1978","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"3-4","key":"10.1002\/14651858.CD001333.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/00952997509005664","article-title":"Experiences with naltrexone in Buffalo","volume":"2","author":"Taintor","year":"1975","journal-title":"American Journal of Drug and Alcohol Abuse"},{"issue":"9","key":"10.1002\/14651858.CD001333.pub3-BIB42|cit42","first-page":"42","article-title":"Clinical experience with naltrexone in suburban opioid addicts","volume":"45","author":"Tennant","year":"1984","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD001333.pub3-BIB43|cit43","first-page":"679","article-title":"Short-term effects of naltrexone in 155 heroin ex-addicts","volume":"11","author":"Volavka","year":"1976","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD001333.pub3-BIB44|cit44","first-page":"54","article-title":"Pharmacotherapy in heroin addiction:pharmacological approaches to remission stabilization and recurrence prevention","volume":"10","author":"Grinenko","year":"2003","journal-title":"Vestn Ross Akad Med Nauk"},{"key":"10.1002\/14651858.CD001333.pub3-BIB45|cit45","unstructured":"Comparison of Buprenorphine\/Naloxone with Naltrexone in opioid dependent patients Ongoing study"},{"key":"10.1002\/14651858.CD001333.pub3-BIB46|cit46","unstructured":"AIHW (Australian Institute of Health and Welfare) Alcohol and other drug treatment services in Australia 2007-08; report of the national minimum dataset Cat. no. HSE 73. Canberra 2009"},{"issue":"3","key":"10.1002\/14651858.CD001333.pub3-BIB47|cit47","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003409.pub3","article-title":"Methadone at tapered doses for the management of opioid withdrawal","author":"Amato","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD001333.pub3-BIB48|cit48","first-page":"49","article-title":"Naltrexone treatment in a jail work-release program","volume":"45","author":"Brahen","year":"1984","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001333.pub3-BIB49|cit49","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002210","article-title":"LAAM maintenance vs methadone maintenance for heroin dependence","author":"Clark","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001333.pub3-BIB50|cit50","unstructured":"European Monitoring Centre for Drugs and Drug Addiction The state of the drugs problem in Europe http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_93236_EN_EMCDDA_AR2009 2009"},{"issue":"3","key":"10.1002\/14651858.CD001333.pub3-BIB51|cit51","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002208","article-title":"Methadone maintenance at different dosages for opioid dependence","author":"Faggiano","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001333.pub3-BIB52|cit52","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008] The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"issue":"9","key":"10.1002\/14651858.CD001333.pub3-BIB53|cit53","first-page":"46","article-title":"Naltrexone treatment for addicted health-care professionals: a collaborative private practice experience","volume":"45","author":"Ling","year":"1984","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD001333.pub3-BIB54|cit54","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006140.pub2","article-title":"Sustained-Release Naltrexone For Opioid Dependence","author":"Lobmaier","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001333.pub3-BIB55|cit55","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub3","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001333.pub3-BIB56|cit56","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"13","key":"10.1002\/14651858.CD001333.pub3-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/jama.284.13.1689","article-title":"Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation","volume":"284","author":"McLellan","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD001333.pub3-BIB58|cit58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/0003-4819-133-1-200007040-00008","article-title":"Pharmacological treatment of heroin dependent patients","volume":"133","author":"O'Connor","year":"2000","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD001333.pub3-BIB59|cit59","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-3565(25)10212-7","article-title":"Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers","volume":"264","author":"Preston","year":"1193","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD001333.pub3-BIB60|cit60","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/02791072.2000.10400238","article-title":"Addiction pharmacotherapy 2000: new options, new challenges","volume":"32","author":"Rawson","year":"2000","journal-title":"Journal of Pscychoactive Drugs"},{"key":"10.1002\/14651858.CD001333.pub3-BIB61|cit61","unstructured":"Results from the 2008 National Survey on Drug Use and Health: National Findings NSDUH Series H-36 HHS publication No SMA09-4434 Rockville"},{"issue":"9148","key":"10.1002\/14651858.CD001333.pub3-BIB62|cit62","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(98)05356-2","article-title":"Role of maintenance treatment in opioid dependence","volume":"353","author":"Ward","year":"1999","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD001333.pub3-BIB63|cit63","first-page":"39","article-title":"Naltrexone in addicted business executives and physicians","volume":"45","author":"Washton","year":"1984","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD001333.pub3-BIB64|cit64","article-title":"Naltrexone maintenance treatment for opioid dependence","author":"Kirchmayer","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD001333.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T06:08:31Z","timestamp":1740895711000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001333.pub3"}},"subtitle":[],"editor":[{"given":"Silvia","family":"Minozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,2,16]]},"references-count":64,"aliases":["10.1002\/14651858.cd001333.pub4"],"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001333.pub3","relation":{},"subject":[],"published":{"date-parts":[[2011,2,16]]}}}